Plasma ascorbic acid and risk of heart disease and cancer by A. Tavani & C. La Vecchia
For personal use. Only reproduce with permission from The Lancet Publishing Group.
2134 THE LANCET • Vol 357 • June 30, 2001
CORRESPONDENCE
CORRESPONDENCE
COMMENTARY
Plasma ascorbic acid and risk of heart disease and cancer
Sir—Kay-Tee Khaw and colleagues
(March 3, p 657)1 report an inverse
association between plasma ascorbic
acid concentrations and mortality in
men and women. They suggest that
increased ascorbic acid intake might
lessen risk of coronary heart disease
and cancers. However, we think 
that the investigators have overinter-
preted their results, since although
adjustment was made for several risk
factors, the potential major con-
founding of the chronic low-grade
inflammatory response was not taken
into account.
This omission is highly pertinent
since evidence suggests that serum
antioxidant concentrations (caro-
tenoids, ascorbic acid) correlate
strongly and inversely with markers 
of inflammation in illness and in
apparently healthy individuals,2,3 and
abundant data suggest that markers 
of low-grade inflammation predict
vascular disease independently of
traditional risk factors.4 Indeed, Khaw
and Woodhouse5 have previously
reported a significant inverse relation
between markers of the acute-phase
response (C-reactive protein and
fibrinogen) and serum ascorbic acid
concentrations in 96 men and women.
Moreover, available evidence from
studies in ill patients2 suggests that 
the observed low ascorbic acid
concentrations do not alter with extra
supplementation of this substance but
rather by resolution of the inflam-
matory response. 
The above observations could also
explain the largely disappointing
results of supplementation trials.
Thus, we urge Khaw and colleagues to
reanalyse their data with correction for
a marker of the inflammatory response
such as C-reactive protein (with a
sensitive assay) or fibrinogen. Only
with such analyses can we start to
dissect the relevance of diet compared
with inflammation in determining
ascorbic acid concentrations and, by
extrapolation, risk of vascular disease
and cancers.
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We entirely agree with the
reservations about vitamin sup-
plementation, which was why we went
into some detail in our analyses,
reporting no overall effect of
supplement use and presenting dietary
data. In our conclusions we were careful
not to recommend ascorbic acid
supplementation, but to state that our
findings lend further support to the
substantial existing evidence for the
benefits of increasing intakes of fruit
and vegetables, the major dietary
sources of vitamin C.
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Author’s reply
Sir—Naveed Sattar and Donald
McMillan would like a reanalysis of the
data with adjustment for a marker of
the inflammatory response such as C-
reactive protein or fibrinogen. We did
not have resources at the baseline
survey to analyse these markers of
inflammation in the cohort, but we plan
to do these analyses in stored frozen
samples.
Low-grade inflammation may indeed
predict vascular disease independent of
traditional risk factors,1 but we think
this variable is not a confounder but a
possible mechanism through which
plasma ascorbic acid, or factors for
which it is a surrogate marker, might
alter disease risk. We have previously
reported that plasma ascorbic acid
relates inversely to markers of inflam-
mation.2 Inflammation could lower
plasma ascorbic acid concentrations;
ascorbic acid, or factors for which it is a
marker, could also modulate the
inflammatory response. We have noted
in the EPIC-Norfolk study and
previous work2 that dietary sources are
a major determinant of plasma ascorbic
acid concentrations. Additionally, the
magnitude of the relation between
plasma ascorbic acid and cardiovascular
disease (2–3-fold difference in risk
between top and bottom quintiles of
ascorbic acid) is larger than that
reported for markers of inflammation.1
Sir—The EPIC-Norfolk prospective
study,1 based on 96 deaths from
ischaemic heart disease among men
and 27 among women, showed an
inverse relation between plasma
ascorbic acid concentration and
mortality. The relative risks for
increasing plasma ascorbic acid
concentration equivalent to an
increase of 20 pmol/L of daily intake
were 0·63 for men and 0·56 for
women.
We analysed the relation between
dietary intake of ascorbic acid and the
risk of acute myocardial infarction
(AMI) by use of data from a
multicentre case-control study done in
Italy between 1995 and 1999. The
study included 507 patients (378 men,
129 women, median age 61 years
[range 25-79]) who had non-fatal
AMI, and 478 controls (297 men, 181
women, median age 59 years, [25-79])
admitted to hospital for acute
disorders unrelated to smoking and
other recognised risk factors for AMI.
We used a validated food frequency
questionnaire for 78 foods or food
groups, and calculated intake of total
energy, and selected macronutrients
and micronutrients by use of an Italian
food-composition database.2 The main
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sources of ascorbic acid in the Italian
diet were citrus fruit (29%), kiwi
(14%), tomatoes (8%), apples, and
pears, citrus fruit juice, and green and
other salads (5–6% each).
The multivariate odds ratios for
subsequent quintiles of ascorbic acid
intake are given in the table. There was
an inverse association between ascorbic
acid intake and AMI risk; the odds
ratio for the highest quintile of intake
compared with the lowest one was
0·55, and the trend in risk was
significant. When the unit was set to 
1 SD of the distribution of controls
(65·8 mg), the continuous odds ratio
was 0·86. The inverse association was
similar in strata of age at diagnosis of
AMI, whereas it was stronger in
current smokers (odds ratio 0·42 [95%
CI 0·19-0·93 for the highest quintile of
intake) compared with non-smokers
(0·69 [0·36-1·30]), and in people with
a body-mass index 25·0 kg/m2 (0·47
[0·25-0·88]) compared with leaner
people (0·83 [0·36-1·88]).
These findings further support the
suggestion that the intake of vegetables
and fruit rich in ascorbic acid is
inversely related to the risk of AMI.
Evidences on the relation between
vegetables, fruit, and ascorbic acid
intake and AMI are not consistent. In
the Physicians’ Health Study cohort,3
the relative risk for men consuming at
least 2·5 servings per day of vegetables
was 0·77. Among studies done in
Mediterranean populations, in an
Italian hospital-based case-control
study,4 based on 287 women, the odds
ratio of AMI for the highest tertile of
intake compared with the lowest was
0·6 for fruit and 0·7 for green
vegetables. However, in a hospital-
based case-control study done in
Greece,5 including 329 cases of
coronary heart disease of both sexes,
researchers noted no association
between ascorbic acid and coronary
heart disease.
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1200, or 2000 IU daily for 8 weeks
compared with placebo. Their plas-
ma concentrations rose but the
investigators questioned the rationale
for vitamin-E supplementation in
healthy individuals since the health
benefits from the additional levels of
vitamin E were no greater than without. 
The average adult stores roughly
1200-1500 mg ascorbic acid and uses
around 3% of this amount per day.
Adding one more serving of ascorbic
acid (8 mg to 65 mg dependent on the
food) would simply not explain the
benefits obtained from the vitamin
alone. The only explanation, which is
far more consistent with the overall
research, was well illustrated by
researchers at Cornell University.4 The
study’s title was “Antioxidant activity of
fresh apples”. The report stated “the
researchers found that the ascorbic acid
in apples is only responsible for a small
portion of the anti-oxidant activity.
Instead, almost all of this activity in
apples is from phytochemicals. Indeed,
previous studies have shown that a 
500 mg ascorbic acid pill might be pro-
oxidant. The Cornell researchers found
that eating 100 g  fresh apple with skins
provided the total anti-oxidant activity
equal to 1500 mg ascorbic acid. What
those findings show is that the
combination of phytochemicals plays a
very important role in anti-oxidant and
anti-cancer activity, and the real health
benefits may come from a phyto-
chemical mixture.” We know that 85%
of the antioxidant activity of fruits and
vegetables comes from chemicals other
than the standard ascorbic acid, vitamin
E, and -carotene, as the Cornell study
illustrates.
This explanation is also likely for
Khaw and colleagues’ study, which
should have been made more clear in
the relevant titles. 
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Ascorbic acid intake (mg/day) AMI (n[%]) Controls (n[%]) Odds ratio (95%)*
<81·8 124 (24·5) 95 (19·9) 1·00 †
81·9–104·7 96 (18·9) 96 (20·1) 0·69 (0·44-1·07)
104·8–133·1 118 (23·3) 96 (20·1) 0·81 (0·52–1·25)
133·2–184·5 92 (18·2) 95 (19·9) 0·73 (0·46–1·16)
>184·5 77 (15·2) 96 (20·1) 0·55 (0·34–0·89)
Continuous 0·86 (0·74–1·01)
AMI=acute myocardial infarction. *Estimates from multiple logistic regression equations for age, sex,
education, physical activity, body-mass index, cholesterol, smoking, coffee, alcohol drinking,
hyperlipidaemia, diabetes, hypertension, total energy intake, and family history of AMI in first-degree
relatives. †Unit set as 1SD (65·8 mg) distribution of controls. 
DIstribution of 507 cases of acute myocardial infarction and 478 controls by dietary
ascorbic acid intake
Sir—The title of the study by Kay-Tee
Khaw and colleagues1 and that of your
March 3 acccompanying Talking Point
exaggerate what the actual study states.
My concern is that you do not fall into
the same headline-grabbing mentality
as much of the lay media.
In this particular case, I do not
believe your headline that the story is
consistent at all with what the study
actually says, and that it is likely to
mislead many consumers and
professionals who do not take the time
to review the actual study or have the
educational background to do so. 
Specifically, the following points
could have been made. The results of
the study show only an associated
benefit of a higher intake of fruit and
vegetables compared with a specific
nutrient, which we already know.
Higher plasma concentrations of
ascorbic acid are not directly reflective
of a direct relation with increased health
benefits. As Jacobs2 and others have
shown, the ascorbic acid concentration
of the white blood cells is always much
higher than that in plasma. There could
be a striking drop in plasma ascorbic
acid with only a moderate to minor
drop in white blood cell concentration
and immunity status. This difference
holds true with all the purported
antioxidants. For example, in a study
by Meagher and colleagues,3 the
participants were given 200, 400, 800,
Sir—Kay-Tee Khaw and colleagues1
show strong inverse associations
between plasma ascorbic acid
concentrations and mortality among
people recruited from general practices
